BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22558136)

  • 1. Strategic cell-cycle regulatory features that provide mammalian cells with tunable G1 length and reversible G1 arrest.
    Pfeuty B
    PLoS One; 2012; 7(4):e35291. PubMed ID: 22558136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
    Chen WJ; Chang CY; Lin JK
    Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
    Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Cdk4/6-dependent phosphorylation gradient regulates the early to late G1 phase transition.
    Kaulich M; Link VM; Lapek JD; Lee YJ; Glass CK; Gonzalez DJ; Dowdy SF
    Sci Rep; 2021 Jul; 11(1):14736. PubMed ID: 34282211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-Phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation.
    Leng X; Connell-Crowley L; Goodrich D; Harper JW
    Curr Biol; 1997 Sep; 7(9):709-12. PubMed ID: 9285720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes.
    Lundberg AS; Weinberg RA
    Mol Cell Biol; 1998 Feb; 18(2):753-61. PubMed ID: 9447971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lin-35 Rb and cki-1 Cip/Kip cooperate in developmental regulation of G1 progression in C. elegans.
    Boxem M; van den Heuvel S
    Development; 2001 Nov; 128(21):4349-59. PubMed ID: 11684669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
    Santamaria D; Ortega S
    Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E-, and A-type cyclin-CDK complexes.
    Sarcevic B; Lilischkis R; Sutherland RL
    J Biol Chem; 1997 Dec; 272(52):33327-37. PubMed ID: 9407125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
    Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
    J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of the G1/S transition.
    Reed SI
    Cancer Surv; 1997; 29():7-23. PubMed ID: 9338094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human astrocytoma cells by the pyrrolo-1,5-benzoxazepine, PBOX-21.
    Mulligan JM; Campiani G; Ramunno A; Nacci V; Zisterer DM
    Biochim Biophys Acta; 2003 Sep; 1639(1):43-52. PubMed ID: 12943967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression.
    Keenan SM; Lents NH; Baldassare JJ
    J Biol Chem; 2004 Feb; 279(7):5387-96. PubMed ID: 14645251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin inhibits cdk4 activation, p 21(WAF1/CIP1) expression and G1-phase progression in transformed mouse fibroblasts.
    Gaben AM; Saucier C; Bedin M; Barbu V; Mester J
    Int J Cancer; 2004 Jan; 108(2):200-6. PubMed ID: 14639603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
    Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
    Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
    Reynisdóttir I; Polyak K; Iavarone A; Massagué J
    Genes Dev; 1995 Aug; 9(15):1831-45. PubMed ID: 7649471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early G1 growth arrest of hybridoma B cells by DMSO involves cyclin D2 inhibition and p21[CIP1] induction.
    Ponzio G; Loubat A; Rochet N; Turchi L; Rezzonico R; Farahi Far D; Dulic V; Rossi B
    Oncogene; 1998 Sep; 17(9):1159-66. PubMed ID: 9764826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin E and its low molecular weight forms in human cancer and as targets for cancer therapy.
    Akli S; Keyomarsi K
    Cancer Biol Ther; 2003; 2(4 Suppl 1):S38-47. PubMed ID: 14508079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity.
    Clark W; Black EJ; MacLaren A; Kruse U; LaThangue N; Vogt PK; Gillespie DA
    Mol Cell Biol; 2000 Apr; 20(7):2529-42. PubMed ID: 10713176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.